Zinc as a modulator of transglutaminase activity – Laboratory and pathophysiological aspects

• Main Authors: Pål Stenberg, Bodil Roth, Bodil Ohlsson
• Format: Article
• Language: English
• Published: Elsevier 2021-01-01
• Series: Journal of Translational Autoimmunity
• Subjects: Autoimmunity; Celiac disease; Citrate; Neurodegeneration; Transglutaminase; Zinc
• Online Access: http://www.sciencedirect.com/science/article/pii/S2589909021000307

For a whole century, citrate has been used as an in vitro anticoagulant via chelation of calcium. Later, also EDTA was introduced as an anticoagulant. An often overlooked fact is that zinc is bound to citrate and EDTA with affinities much greater than that for calcium, imposing problems in biomedical research. In vivo, proteins of the S100 family are released from leukocytes and known to bind calcium. Some of them, e.g., calprotectin, also chelate zinc. Thus, at an inflamed site, the ratio between Ca2+ and Zn2+ is changed. This mechanism is of importance for the modulation of the activation of a fascinating family of post-translationally acting calcium-dependent thiol enzymes, the transglutaminases, which are inhibited by zinc. This presentation illustrates the complexity of in vitro studies with zinc. Moreover, it exemplifies the role of Zn2+ in pathophysiological situations such as celiac disease and neurodegeneration.